(Nasdaq: HOLX) announced today that its Genius™ Digital Diagnostics System achieved expanded CE marking in the European Union and is now approved to image and review both cell and tissue specimens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback